Immuto Scientific provides high-resolution structural analysis of proteins and peptides using its proprietary PLIMB platform, enabling rapid characterization and optimization of drug candidates. This technology addresses the challenge of inefficient lead optimization by delivering detailed structural insights in just weeks, facilitating faster and more informed therapeutic development.
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SAFounders
Product
Problem
Traditional methods for determining protein and peptide structures are often slow and costly, hindering efficient lead optimization in drug discovery. The lack of rapid, high-resolution structural information limits the ability to rationally design and optimize therapeutic candidates.
Solution
Immuto Scientific offers high-resolution protein and peptide structural analysis services using its proprietary PLIMB (Protein-Ligand Interaction Mass Spectrometry Based) platform. This platform delivers native-state structures at amino acid resolution in a matter of weeks, enabling faster and more informed therapeutic development. By providing detailed insights into protein structure, dynamics, and interactions, Immuto Scientific facilitates rational drug design and accelerates the identification of promising lead candidates. The technology supports multiplexed analysis, allowing for simultaneous screening of multiple lead candidates, and is compatible with challenging targets such as membrane proteins.
Target Audience
The primary customers are pharmaceutical and biotechnology companies involved in drug discovery and development, particularly those focused on protein therapeutics and peptide-based drugs.
Features
- High-resolution protein structure determination at amino acid resolution
- Rapid turnaround time, delivering results in weeks
- Native-state analysis for biologically relevant structural information
- Multiplexed analysis for simultaneous screening of multiple lead candidates
- Compatible with challenging membrane protein targets, including GPCRs
- Applications include target characterization, high-throughput structural screening, structure-based lead optimization, aggregation analysis, epitope/paratope interaction analysis, protein-small molecule interaction analysis, protein-protein interaction analysis, higher-order structure analysis, and antibody aggregation analysis